K. Pasquevich

发表

Unlipidated Outer Membrane Protein Omp16 (U-Omp16) from Brucella spp. as Nasal Adjuvant Induces a Th1 Immune Response and Modulates the Th2 Allergic Response to Cow’s Milk Proteins

S. Oliveira, M. Delpino, C. A. Fossati, 2013, PloS one.

Safety, tolerability, and immunogenicity of a new SARS-CoV-2 recombinant Gamma variant RBD-based protein adjuvanted vaccine, used as heterologous booster in healthy adults: a Phase 1 interim report.

J. Vega, A. Ceballos, J. Geffner, 2023, medRxiv.

Characterization of Two New Copper(II) Complexes with Saccharinate and Benzimidazole as Ligands

P. A. Williams, E. G. Ferrer, E. Castellano, 2000 .

Structural and spectroscopic characterization of tris (o-phenanthroline)iron(II) disaccharinate monosaccharin hexahydrate

P. A. Williams, E. G. Ferrer, E. Castellano, 2000 .

Omp19 Enables Brucella abortus to Evade the Antimicrobial Activity From Host's Proteolytic Defense System

D. Comerci, Francisco Guaimas, J. Cassataro, 2019, Front. Immunol..

Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier

Francisco Guaimas, J. Cassataro, Karina A. Pasquevich, 2019, Journal of controlled release : official journal of the Controlled Release Society.

U-Omp19 from Brucella abortus Is a Useful Adjuvant for Vaccine Formulations against Salmonella Infection in Mice

S. McSorley, G. Briones, Seung‐Joo Lee, 2017, Front. Immunol..

A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses.

F. Frank, G. Briones, F. Goldbaum, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Brucella lipoproteins mimic dendritic cell maturation induced by Brucella abortus.

M. Delpino, C. A. Fossati, G. Giambartolomei, 2008, Microbes and infection.

Brucella abortus Inhibits Major Histocompatibility Complex Class II Expression and Antigen Processing through Interleukin-6 Secretion via Toll-Like Receptor 2

M. Delpino, C. A. Fossati, G. Giambartolomei, 2007, Infection and Immunity.

and Oral Acquired Brucellosis Self-Adjuvanting Vaccine against Systemic Th1 Immune Response, and Is a Promising Activates Dendritic Cells In Vivo, Induces a Pathogen-Associated Molecular Pattern That Membrane Protein 16 Is a New Bacterial Outer Brucella abortus The Protein Moiety of

Fernanda S. Oliveira, J. Borkowski, H. Warzecha, 2017 .

The Protein Moiety of Brucella abortus Outer Membrane Protein 16 Is a New Bacterial Pathogen-Associated Molecular Pattern That Activates Dendritic Cells In Vivo, Induces a Th1 Immune Response, and Is a Promising Self-Adjuvanting Vaccine against Systemic and Oral Acquired Brucellosis

Fernanda S. Oliveira, J. Borkowski, S. Oliveira, 2010, The Journal of Immunology.

An Oral Vaccine Based on U-Omp19 Induces Protection against B. abortus Mucosal Challenge by Inducing an Adaptive IL-17 Immune Response in Mice

Fernanda S. Oliveira, S. Oliveira, H. Warzecha, 2011, PloS one.

Immunization with Recombinant Brucella Species Outer Membrane Protein Omp16 or Omp19 in Adjuvant Induces Specific CD4+ and CD8+ T Cells as Well as Systemic and Oral Protection against Brucella abortus Infection

S. Estein, C. A. Fossati, G. Giambartolomei, 2008, Infection and Immunity.

A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.

D. Laplagne, F. Goldbaum, S. Estein, 2007, Vaccine.

A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice

D. Alvarez, Julieta Alcain, J. Cassataro, 2022, Frontiers in Immunology.

A novel bacterial protease inhibitor adjuvant in RBD-based COVID-19 vaccine formulations increases neutralizing antibodies, specific germinal center B cells and confers protection against SARS-CoV-2 infection

Lucía B. Chemes, D. Alvarez, Julieta Alcain, 2021, bioRxiv.

Systemic bacterial infections affect dendritic cell development and function.

Karina A. Pasquevich, K. Bieber, S. Autenrieth, 2021, International journal of medical microbiology : IJMM.

Depletion of Dendritic Cells Enhances Innate Anti-Bacterial Host Defense through Modulation of Phagocyte Homeostasis

I. Autenrieth, S. Beer-Hammer, Y. Samstag, 2012, PLoS pathogens.

Antibody Reactivity to Omp31 from Brucella melitensis in Human and Animal Infections by Smooth and Rough Brucellae

C. A. Fossati, P. Baldi, J. Cassataro, 2004, Clinical Diagnostic Laboratory Immunology.

A DNA Vaccine Coding for the Brucella Outer Membrane Protein 31 Confers Protection against B. melitensis and B. ovis Infection by Eliciting a Specific Cytotoxic Response

S. Estein, G. Giambartolomei, J. Cassataro, 2005, Infection and Immunity.

Brucella abortus activates human neutrophils.

M. Delpino, G. Giambartolomei, P. Barrionuevo, 2009, Microbes and infection.

Vaccination with the Recombinant Brucella Outer Membrane Protein 31 or a Derived 27-Amino-Acid Synthetic Peptide Elicits a CD4+ T Helper 1 Response That Protects against Brucella melitensis Infection

S. Estein, G. Giambartolomei, J. Cassataro, 2005, Infection and Immunity.

RomA, A Periplasmic Protein Involved in the Synthesis of the Lipopolysaccharide, Tunes Down the Inflammatory Response Triggered by Brucella

C. Czibener, Juan E Ugalde, S. Altabe, 2018, The Journal of infectious diseases.

Omp25‐dependent engagement of SLAMF1 by Brucella abortus in dendritic cells limits acute inflammation and favours bacterial persistence in vivo

J. Gorvel, S. Méresse, Gabriela González-Espinoza, 2020, Cellular microbiology.

A DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination.

D. Laplagne, F. Goldbaum, S. Estein, 2007, Vaccine.

Stability Studies of the Vaccine Adjuvant U-Omp19

J. Cassataro, Karina A. Pasquevich, Laura A. Bruno, 2020, Journal of pharmaceutical sciences.

A disordered region retains the full protease inhibitor activity and the capacity to induce CD8+ T cells in vivo of the oral vaccine adjuvant U-Omp19

Lucía B. Chemes, Rodolfo M. Rasia, J. Cassataro, 2022, Computational and structural biotechnology journal.

U-Omp19 from Brucella abortus increases dmLT immunogenicity and improves protection against Escherichia coli heat-labile toxin (LT) oral challenge

J. Cassataro, Karina A. Pasquevich, Lorena M. Coria, 2020, Vaccine.

Innate immune system favors emergency monopoiesis at the expense of DC‐differentiation to control systemic bacterial infection in mice

C. Lengerke, H. Rammensee, L. Zender, 2015, European journal of immunology.

A Brucella spp. Protease Inhibitor Limits Antigen Lysosomal Proteolysis, Increases Cross-Presentation, and Enhances CD8+ T Cell Responses

M. Tkach, R. Schillaci, A. Trevani, 2016, The Journal of Immunology.

Brucella abortus induces the secretion of proinflammatory mediators from glial cells leading to astrocyte apoptosis.

P. Mathieu, F. Pitossi, M. Delpino, 2010, The American journal of pathology.

Bm Delta-pgm, a vaccine for the control of Brucella melitensis with cross-species protective properties.

C. Czibener, D. Comerci, J. Cassataro, 2023, Vaccine.

Brucella abortus Omp19 recombinant protein subcutaneously co-delivered with an antigen enhances antigen-specific T helper 1 memory responses and induces protection against parasite challenge.

F. Frank, G. Giambartolomei, J. Cassataro, 2016, Vaccine.